Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v4-EN | |
---|---|---|
Language | French | English |
Date Updated | 2024-08-08 | 2023-08-31 |
Drug Identification Number | 02485613 | 02485613 |
Brand name | OXERVATE | OXERVATE |
Common or Proper name | CENEGERMIN | CENEGERMIN |
Company Name | DOMPÉ FARMACEUTICI S.P.A. | DOMPÉ FARMACEUTICI S.P.A. |
Ingredients | ||
Strength(s) | 0.002% | 0.002% |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | OPHTHALMIC | OPHTHALMIC |
Packaging size | 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS | 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS |
ATC code | S01XA | S01XA |
ATC description | ||
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2023-08-30 | 2023-08-30 |
Actual start date | ||
Estimated end date | Unknown | Unknown |
Actual end date | 2024-07-17 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | SUPPLY OF CANADIAN LABELLED OXERVATE IS BEING DEPLETED/NEAR EXPIRY AND CANNOT BE REPLENISHED DUE TO LIMITED DEMAND AND SUPPLY CHALLENGES. | SUPPLY OF CANADIAN LABELLED OXERVATE IS BEING DEPLETED/NEAR EXPIRY AND CANNOT BE REPLENISHED DUE TO LIMITED DEMAND AND SUPPLY CHALLENGES. |
Health Canada comments | A discontinuation report will be submitted. Expiry date of the last lot 21L7641 sold on the Canadian market was June 22, 2024. An official notification was submitted to Health Canada on July 31st. |